Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,942 | -1,684 | -2,810 | -1,794 | -1,043 |
| Depreciation Amortization | 378 | 188 | 710 | 530 | 352 |
| Income taxes - deferred | N/A | N/A | -1,657 | -1,139 | -656 |
| Accounts payable and accrued liabilities | 71 | 34 | 125 | 157 | 118 |
| Other Working Capital | -576 | -159 | 30 | 149 | 147 |
| Other Operating Activity | 318 | 159 | 292 | 110 | 43 |
| Operating Cash Flow | $-3,751 | $-1,462 | $-3,310 | $-1,987 | $-1,039 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -39 | -80 | -73 | -34 |
| Purchase Of Investment | -495 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-556 | $-39 | $-80 | $-73 | $-34 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,915 | N/A | N/A | 0 | N/A |
| Financing Cash Flow | $20,915 | $N/A | $0 | $N/A | $N/A |
| Beginning Cash Position | 3,606 | 3,606 | 7,000 | 7,009 | 7,009 |
| End Cash Position | 20,214 | 2,105 | 3,600 | 4,949 | 5,936 |
| Net Cash Flow | $16,608 | $-1,501 | $-3,400 | $-2,060 | $-1,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,751 | -1,462 | -3,310 | -1,987 | -1,039 |
| Capital Expenditure | -61 | -39 | -86 | -73 | -34 |
| Free Cash Flow | -3,812 | -1,501 | -3,396 | -2,060 | -1,073 |